Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Clinical trial NCT05491226 · RECRUITING

Trial details

NCT number: NCT05491226
Sponsor: Stephen Shiao
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer Breast Cancer

Start date: 2023-11-17
Primary completion: 2026-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.